Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Current Biology : CB
|
November 21, 1998
TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis
M Oft, K H Heider, H Beug
Urological Research
|
January 1, 1995
Prognostic factors for bladder cancer
T Otto, M Goepel, K H Heider, et al.
Virchows Archiv : an International Journal of Pathology
|
July 1, 1996
Expression of CD44 isoforms in human renal cell carcinomas
K H Heider, M Ratschek, K Zatloukal, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
October 29, 2000
Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer
E Mizera-Nyczak, W Dyszkiewicz, K H Heider, et al.
The Journal of Pathology
|
April 21, 1999
Expression of CD44 splice variant v10 in Hodgkin's disease is associated with aggressive behaviour and high risk of relapse
C Beham-Schmid, K H Heider, G Hoefler, et al.
Leukemia & Lymphoma
|
June 1, 1999
Expression of CD44 isoforms on isolated bone marrow plasma cells and peripheral CD19+ B cells of patients with multiple myeloma and healthy individuals
J Schuster-Kolbe, H Ludwig, G R Adolf, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
August 1, 1995
Importance of different CD44v6 expression in human gastric intestinal and diffuse type cancers for metastatic lymphogenic spreading
J Dämmrich, H P Vollmers, K H Heider, et al.
Lancet (London, England)
|
April 13, 1996
Expression of CD44v6 in ulcerative colitis and Crohn's disease
W Reinisch, K H Heider, G Oberhuber, et al.
The Journal of Pathology
|
December 9, 1997
Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer
W Müller, A Schneiders, K H Heider, et al.
Lancet (London, England)
|
August 19, 1995
CD44 isoforms in prognosis of breast cancer
M Kaufmann, K H Heider, H P Sinn, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Current Biology : CB
|
November 21, 1998
TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis
M Oft, K H Heider, H Beug
Urological Research
|
January 1, 1995
Prognostic factors for bladder cancer
T Otto, M Goepel, K H Heider, et al.
Virchows Archiv : an International Journal of Pathology
|
July 1, 1996
Expression of CD44 isoforms in human renal cell carcinomas
K H Heider, M Ratschek, K Zatloukal, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
October 29, 2000
Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer
E Mizera-Nyczak, W Dyszkiewicz, K H Heider, et al.
The Journal of Pathology
|
April 21, 1999
Expression of CD44 splice variant v10 in Hodgkin's disease is associated with aggressive behaviour and high risk of relapse
C Beham-Schmid, K H Heider, G Hoefler, et al.
Leukemia & Lymphoma
|
June 1, 1999
Expression of CD44 isoforms on isolated bone marrow plasma cells and peripheral CD19+ B cells of patients with multiple myeloma and healthy individuals
J Schuster-Kolbe, H Ludwig, G R Adolf, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
August 1, 1995
Importance of different CD44v6 expression in human gastric intestinal and diffuse type cancers for metastatic lymphogenic spreading
J Dämmrich, H P Vollmers, K H Heider, et al.
Lancet (London, England)
|
April 13, 1996
Expression of CD44v6 in ulcerative colitis and Crohn's disease
W Reinisch, K H Heider, G Oberhuber, et al.
The Journal of Pathology
|
December 9, 1997
Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer
W Müller, A Schneiders, K H Heider, et al.
Lancet (London, England)
|
August 19, 1995
CD44 isoforms in prognosis of breast cancer
M Kaufmann, K H Heider, H P Sinn, et al.
Page
of 4